-
1
-
-
0036049558
-
Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle
-
Abadie, J., V. Blouin, L. Guigand, M. Wyers, and Y. Cherel. 2002. Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle. Gene Ther. 9:1037-1043.
-
(2002)
Gene Ther.
, vol.9
, pp. 1037-1043
-
-
Abadie, J.1
Blouin, V.2
Guigand, L.3
Wyers, M.4
Cherel, Y.5
-
2
-
-
0035815437
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
-
Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
-
(2001)
Science
, vol.292
, pp. 69-74
-
-
Amara, R.R.1
Villinger, F.2
Altman, J.D.3
Lydy, S.L.4
O'Neil, S.P.5
Staprans, S.I.6
Montefiori, D.C.7
Xu, Y.8
Herndon, J.G.9
Wyatt, L.S.10
Candido, M.A.11
Kozyr, N.L.12
Earl, P.L.13
Smith, J.M.14
Ma, H.L.15
Grimm, B.D.16
Hulsey, M.L.17
Miller, J.18
McClure, H.M.19
McNicholl, J.M.20
Moss, B.21
Robinson, H.L.22
more..
-
3
-
-
0036310296
-
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines
-
Amara, R. R., F. Villinger, S. I. Staprans, J. D. Altman, D. C. Montefiori, N. L. Kozyr, Y. Xu, L. S. Wyatt, P. L. Earl, J. G. Herndon, H. M. McClure, B. Moss, and H. L. Robinson. 2002. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines. J. Virol. 76:7625-7631.
-
(2002)
J. Virol.
, vol.76
, pp. 7625-7631
-
-
Amara, R.R.1
Villinger, F.2
Staprans, S.I.3
Altman, J.D.4
Montefiori, D.C.5
Kozyr, N.L.6
Xu, Y.7
Wyatt, L.S.8
Earl, P.L.9
Herndon, J.G.10
McClure, H.M.11
Moss, B.12
Robinson, H.L.13
-
4
-
-
12144291311
-
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: Application in epidemiologic studies and in the design of adenovector vaccines
-
Aste-Amezaga, M., A. J. Bett, F. Wang, D. R. Casimiro, J. M. Antonello, D. K. Patel, E. C. Dell, L. L. Franlin, N. M. Dougherty, P. S. Bennett, H. C. Perry, M. E. Davies, J. W. Shiver, P. M. Keller, and M. D. Yeager. 2004. Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum. Gene Ther. 15:293-304.
-
(2004)
Hum. Gene Ther.
, vol.15
, pp. 293-304
-
-
Aste-Amezaga, M.1
Bett, A.J.2
Wang, F.3
Casimiro, D.R.4
Antonello, J.M.5
Patel, D.K.6
Dell, E.C.7
Franlin, L.L.8
Dougherty, N.M.9
Bennett, P.S.10
Perry, H.C.11
Davies, M.E.12
Shiver, J.W.13
Keller, P.M.14
Yeager, M.D.15
-
5
-
-
0035501136
-
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys
-
Barouch, D. H., T. M. Fu, D. C. Montefiori, M. G. Lewis, J. W. Shiver, and N. L. Lervin. 2001. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunol. Lett. 79:57-61.
-
(2001)
Immunol. Lett.
, vol.79
, pp. 57-61
-
-
Barouch, D.H.1
Fu, T.M.2
Montefiori, D.C.3
Lewis, M.G.4
Shiver, J.W.5
Lervin, N.L.6
-
6
-
-
0034571011
-
Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys
-
Barouch, D. H., and N. L. Letvin. 2000. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys. Dev. Biol. 104:85-92.
-
(2000)
Dev. Biol.
, vol.104
, pp. 85-92
-
-
Barouch, D.H.1
Letvin, N.L.2
-
7
-
-
0033766645
-
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
-
Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, K. Beaudry, M. A. Lifton, C. E. Nickerson, W. L. Trigona, K. Punt, D. C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M. E. Davies, M. Chastain, T. B. Strom, R. S. Gelman, D. C. Montefiori, M. G. Lewis, E. A. Emini, J. W. Shiver, and N. L. Letvin. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290: 486-492.
-
(2000)
Science
, vol.290
, pp. 486-492
-
-
Barouch, D.H.1
Santra, S.2
Schmitz, J.E.3
Kuroda, M.J.4
Fu, T.M.5
Wagner, W.6
Bilska, M.7
Craiu, A.8
Zheng, X.X.9
Krivulka, G.R.10
Beaudry, K.11
Lifton, M.A.12
Nickerson, C.E.13
Trigona, W.L.14
Punt, K.15
Freed, D.C.16
Guan, L.17
Dubey, S.18
Casimiro, D.19
Simon, A.20
Davies, M.E.21
Chastain, M.22
Strom, T.B.23
Gelman, R.S.24
Montefiori, D.C.25
Lewis, M.G.26
Emini, E.A.27
Shiver, J.W.28
Letvin, N.L.29
more..
-
8
-
-
0033987322
-
Adeno-associated virus based gene therapy in skeletal muscle
-
Bartlett, R. J., and J. M. McCue. 2000. Adeno-associated virus based gene therapy in skeletal muscle. Methods Mol. Biol. 133:127-156.
-
(2000)
Methods Mol. Biol.
, vol.133
, pp. 127-156
-
-
Bartlett, R.J.1
McCue, J.M.2
-
9
-
-
12144289214
-
Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates
-
Bertley, F. M., P. A. Kozlowski, S. W. Wang, J. Chappelle, J. Patel, O. Sonuyi, G. Mazzara, D. Montefiori, A. Carrille, K. G. Mansfield, and A. Aldovini. 2004. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. J. Immunol. 172:3745-3757.
-
(2004)
J. Immunol.
, vol.172
, pp. 3745-3757
-
-
Bertley, F.M.1
Kozlowski, P.A.2
Wang, S.W.3
Chappelle, J.4
Patel, J.5
Sonuyi, O.6
Mazzara, G.7
Montefiori, D.8
Carrille, A.9
Mansfield, K.G.10
Aldovini, A.11
-
10
-
-
0029817995
-
Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors
-
Bertran, J., J. L. Miller, Y. Yang, A. Fenimore-Justman, F. Rueda, E. F. Vanin, and A. W. Nienhuis. 1996. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J. Virol. 70:6759-6766.
-
(1996)
J. Virol.
, vol.70
, pp. 6759-6766
-
-
Bertran, J.1
Miller, J.L.2
Yang, Y.3
Fenimore-Justman, A.4
Rueda, F.5
Vanin, E.F.6
Nienhuis, A.W.7
-
11
-
-
0033026062
-
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
-
Cafaro, A., A. Caputo, C. Fracasso, M. T. Maggiorella, D. Goletti, S. Baroncelli, M. Pace, L. Sernicola, M. L. Koanga-Mogtomo, M. Betti, A. Borsetti, R. Belli, L. Akerblom, F. Corrias, S. Butto, J. Heeney, P. Verani, F. Titti, and B. Ensoli. 1999. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med. 5:643-650.
-
(1999)
Nat. Med.
, vol.5
, pp. 643-650
-
-
Cafaro, A.1
Caputo, A.2
Fracasso, C.3
Maggiorella, M.T.4
Goletti, D.5
Baroncelli, S.6
Pace, M.7
Sernicola, L.8
Koanga-Mogtomo, M.L.9
Betti, M.10
Borsetti, A.11
Belli, R.12
Akerblom, L.13
Corrias, F.14
Butto, S.15
Heeney, J.16
Verani, P.17
Titti, F.18
Ensoli, B.19
-
12
-
-
0033807492
-
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
-
Cafaro, A., A. Caputo, M. T. Maggiorella, S. Baroncelli, C. Fracasso, M. Pace, A. Borsetti, L. Sernicola, D. R. Negri, P. Ten Haaft, M. Betti, Z. Michelini, I. Macchia, E. Fanales-Belasio, R. Belli, F. Corrias, S. Butto, P. Verani, F. Titti, and B. Ensoli. 2000. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. J. Med. Primatol. 29:193-208.
-
(2000)
J. Med. Primatol.
, vol.29
, pp. 193-208
-
-
Cafaro, A.1
Caputo, A.2
Maggiorella, M.T.3
Baroncelli, S.4
Fracasso, C.5
Pace, M.6
Borsetti, A.7
Sernicola, L.8
Negri, D.R.9
Ten Haaft, P.10
Betti, M.11
Michelini, Z.12
Macchia, I.13
Fanales-Belasio, E.14
Belli, R.15
Corrias, F.16
Butto, S.17
Verani, P.18
Titti, F.19
Ensoli, B.20
more..
-
13
-
-
0035815501
-
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)
-
Cafaro, A., F. Titti, C. Fracasso, M. T. Maggiorella, S. Baroncelli, A. Caputo, D. Goletti, A. Borsetti, M. Pace, E. Fanales-Belasio, B. Ridolfi, D. R. Negri, L. Sernicola, R. Belli, F. Corrias, I. Macchia, P. Leone, Z. Michelini, P. ten Haaft, S. Butto, P. Verani, and B. Ensoli. 2001. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine 19:2862-2877.
-
(2001)
Vaccine
, vol.19
, pp. 2862-2877
-
-
Cafaro, A.1
Titti, F.2
Fracasso, C.3
Maggiorella, M.T.4
Baroncelli, S.5
Caputo, A.6
Goletti, D.7
Borsetti, A.8
Pace, M.9
Fanales-Belasio, E.10
Ridolfi, B.11
Negri, D.R.12
Sernicola, L.13
Belli, R.14
Corrias, F.15
Macchia, I.16
Leone, P.17
Michelini, Z.18
Ten Haaft, P.19
Butto, S.20
Verani, P.21
Ensoli, B.22
more..
-
14
-
-
0034572459
-
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
-
Chao, H., Y. Liu, J. Rabinowitz, C. Li, R. J. Samulski, and C. E. Walsh. 2000. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2:619-623.
-
(2000)
Mol. Ther.
, vol.2
, pp. 619-623
-
-
Chao, H.1
Liu, Y.2
Rabinowitz, J.3
Li, C.4
Samulski, R.J.5
Walsh, C.E.6
-
15
-
-
1942521650
-
Autoimmune anemia in macaques following erythropoietin gene therapy
-
Chenuaud, P., T. Larchet, J. E. Rabinowitz, N. Provost, Y. Cherel, N. Casadevall, R. J. Samulski, and P. Moullier. 2004. Autoimmune anemia in macaques following erythropoietin gene therapy. Blood 103:3303-3304.
-
(2004)
Blood
, vol.103
, pp. 3303-3304
-
-
Chenuaud, P.1
Larchet, T.2
Rabinowitz, J.E.3
Provost, N.4
Cherel, Y.5
Casadevall, N.6
Samulski, R.J.7
Moullier, P.8
-
16
-
-
0036175095
-
Recent advances in recombinant adeno-associated virus vector production
-
Clark, K. R. 2002. Recent advances in recombinant adeno-associated virus vector production. Kidney Int. 61(Suppl. 1):9-15.
-
(2002)
Kidney Int.
, vol.61
, Issue.SUPPL. 1
, pp. 9-15
-
-
Clark, K.R.1
-
17
-
-
0034879346
-
Gene delivery of vaccines for infectious disease
-
Clark, K. R., and P. R. Johnson. 2001. Gene delivery of vaccines for infectious disease. Curr. Opin. Mol. Ther. 3:375-384.
-
(2001)
Curr. Opin. Mol. Ther.
, vol.3
, pp. 375-384
-
-
Clark, K.R.1
Johnson, P.R.2
-
18
-
-
0033541640
-
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
-
Clark, K. R., X. Liu, J. P. McGrath, and P. R. Johnson. 1999. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1031-1039.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 1031-1039
-
-
Clark, K.R.1
Liu, X.2
McGrath, J.P.3
Johnson, P.R.4
-
19
-
-
0030970938
-
Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle
-
Clark, K. R., T. J. Sferra, and P. R. Johnson. 1997. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8:659-669.
-
(1997)
Hum. Gene Ther.
, vol.8
, pp. 659-669
-
-
Clark, K.R.1
Sferra, T.J.2
Johnson, P.R.3
-
20
-
-
0028889443
-
Cell lines for the production of recombinant adeno-associated virus
-
Clark, K. R., F. Voulgaropoulou, D. M. Fraley, and P. R. Johnson. 1995. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6:1329-1341.
-
(1995)
Hum. Gene Ther.
, vol.6
, pp. 1329-1341
-
-
Clark, K.R.1
Voulgaropoulou, F.2
Fraley, D.M.3
Johnson, P.R.4
-
21
-
-
0030458783
-
A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors
-
Clark, K. R., F. Voulgaropoulou, and P. R. Johnson. 1996. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3:1124-1132.
-
(1996)
Gene Ther.
, vol.3
, pp. 1124-1132
-
-
Clark, K.R.1
Voulgaropoulou, F.2
Johnson, P.R.3
-
22
-
-
0029741735
-
Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung
-
Conrad, C. K., S. S. Allen, S. A. Afione, T. C. Reynolds, S. E. Beck, M. Fee-Maki, X. Barrazza-Ortiz, R. Adams, F. B. Askin, B. J. Carter, W. B. Guggino, and T. R. Flotte. 1996. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3:658-668.
-
(1996)
Gene Ther.
, vol.3
, pp. 658-668
-
-
Conrad, C.K.1
Allen, S.S.2
Afione, S.A.3
Reynolds, T.C.4
Beck, S.E.5
Fee-Maki, M.6
Barrazza-Ortiz, X.7
Adams, R.8
Askin, F.B.9
Carter, B.J.10
Guggino, W.B.11
Flotte, T.R.12
-
23
-
-
0034821320
-
+ T lymphocytes in naive and simian immunodeficiency virus-infected rhesus monkeys
-
+ T lymphocytes in naive and simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum. Retrovir. 17:873-886.
-
(2001)
AIDS Res. Hum. Retrovir.
, vol.17
, pp. 873-886
-
-
Craiu, A.1
Barouch, D.H.2
Zheng, X.X.3
Kuroda, M.J.4
Schmitz, J.E.5
Lifton, M.A.6
Steenbeke, T.D.7
Nickerson, C.E.8
Beaudry, K.9
Frost, J.D.10
Reimann, K.A.11
Strom, T.B.12
Letvin, N.L.13
-
24
-
-
0033988633
-
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
-
Davis, N. L., I. J. Caley, K. W. Brown, M. R. Betts, D. M. Irlbeck, K. M. McGrath, M. J. Connell, D. C. Montefiori, J. A. Frelinger, R. Swanstrom, P. R. Johnson, and R. E. Johnston. 2000. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J. Virol. 74:371-378.
-
(2000)
J. Virol.
, vol.74
, pp. 371-378
-
-
Davis, N.L.1
Caley, I.J.2
Brown, K.W.3
Betts, M.R.4
Irlbeck, D.M.5
McGrath, K.M.6
Connell, M.J.7
Montefiori, D.C.8
Frelinger, J.A.9
Swanstrom, R.10
Johnson, P.R.11
Johnston, R.E.12
-
25
-
-
10744221758
-
+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge
-
+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. J. Virol. 77:11563-11577.
-
(2003)
J. Virol.
, vol.77
, pp. 11563-11577
-
-
Doria-Rose, N.A.1
Ohlen, C.2
Polacino, P.3
Pierce, C.C.4
Hensel, M.T.5
Kuller, L.6
Mulvania, T.7
Andersen, D.8
Greenberg, P.D.9
Hu, S.L.10
Haigwood, N.L.11
-
26
-
-
0031691257
-
Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue
-
Erratum 73:861, 1999
-
Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:8568-8577. (Erratum 73:861, 1999.)
-
(1998)
J. Virol.
, vol.72
, pp. 8568-8577
-
-
Duan, D.1
Sharma, P.2
Yang, J.3
Yue, Y.4
Dudus, L.5
Zhang, Y.6
Fisher, K.J.7
Engelhardt, J.F.8
-
27
-
-
0034907414
-
Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation
-
Duan, D., Z. Yan, Y. Yue, W. Ding, and J. F. Engelhardt. 2001. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75:7662-7671.
-
(2001)
J. Virol.
, vol.75
, pp. 7662-7671
-
-
Duan, D.1
Yan, Z.2
Yue, Y.3
Ding, W.4
Engelhardt, J.F.5
-
28
-
-
17944388584
-
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
-
During, M. J., C. W. Symes, P. A. Lawlor, J. Lin, J. Dunning, H. L. Fitzsimons, D. Poulsen, P. Leone, R. Xu, B. L. Dicker, J. Lipski, and D. Young. 2000. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 287:1453-1460.
-
(2000)
Science
, vol.287
, pp. 1453-1460
-
-
During, M.J.1
Symes, C.W.2
Lawlor, P.A.3
Lin, J.4
Dunning, J.5
Fitzsimons, H.L.6
Poulsen, D.7
Leone, P.8
Xu, R.9
Dicker, B.L.10
Lipski, J.11
Young, D.12
-
29
-
-
0036056987
-
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model
-
Earl, P. L., L. S. Wyatt, D. C. Montefiori, M. Bilska, R. Woodward, P. D. Markham, J. D. Malley, T. U. Vogel, T. M. Allen, D. I. Watkins, N. Miller, and B. Moss. 2002. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model. Virology 294:270-281.
-
(2002)
Virology
, vol.294
, pp. 270-281
-
-
Earl, P.L.1
Wyatt, L.S.2
Montefiori, D.C.3
Bilska, M.4
Woodward, R.5
Markham, P.D.6
Malley, J.D.7
Vogel, T.U.8
Allen, T.M.9
Watkins, D.I.10
Miller, N.11
Moss, B.12
-
30
-
-
0033868431
-
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection
-
Egan, M. A., W. A. Charini, M. J. Kuroda, J. E. Schmitz, P. Racz, K. Tenner-Racz, K. Manson, M. Wyand, M. A. Lifton, C. E. Nickerson, T. Fu, J. W. Shiver, and N. L. Letvin. 2000. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J. Virol. 74:7485-7495.
-
(2000)
J. Virol.
, vol.74
, pp. 7485-7495
-
-
Egan, M.A.1
Charini, W.A.2
Kuroda, M.J.3
Schmitz, J.E.4
Racz, P.5
Tenner-Racz, K.6
Manson, K.7
Wyand, M.8
Lifton, M.A.9
Nickerson, C.E.10
Fu, T.11
Shiver, J.W.12
Letvin, N.L.13
-
31
-
-
0033028598
-
+ cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
-
+ cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys. J. Virol. 73:5466-5472.
-
(1999)
J. Virol.
, vol.73
, pp. 5466-5472
-
-
Egan, M.A.1
Kuroda, M.J.2
Voss, G.3
Schmitz, J.E.4
Charini, W.A.5
Lord, C.I.6
Forman, M.A.7
Letvin, N.L.8
-
32
-
-
0035667722
-
Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle
-
Favre, D., N. Provost, V. Blouin, G. Blancho, Y. Cherel, A. Salvetti, and P. Moullier. 2001. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol. Ther. 4:559-566.
-
(2001)
Mol. Ther.
, vol.4
, pp. 559-566
-
-
Favre, D.1
Provost, N.2
Blouin, V.3
Blancho, G.4
Cherel, Y.5
Salvetti, A.6
Moullier, P.7
-
33
-
-
0024978864
-
Cationic liposome-mediated transfection
-
Feigner, P. L., and G. M. Ringold. 1989. Cationic liposome-mediated transfection. Nature 337:387-388.
-
(1989)
Nature
, vol.337
, pp. 387-388
-
-
Feigner, P.L.1
Ringold, G.M.2
-
34
-
-
0031058024
-
Recombinant adeno-associated virus for muscle directed gene therapy
-
Fisher, K. J., K. Jooss, J. Alston, Y. Yang, S. E. Haecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
-
(1997)
Nat. Med.
, vol.3
, pp. 306-312
-
-
Fisher, K.J.1
Jooss, K.2
Alston, J.3
Yang, Y.4
Haecker, S.E.5
High, K.6
Pathak, R.7
Raper, S.E.8
Wilson, J.M.9
-
35
-
-
0038488551
-
Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study
-
Flotte, T. R., P. L. Zeitlin, T. C. Reynolds, A. E. Heald, P. Pedersen, S. Beck, C. K. Conrad, L. Brass-Ernst, M. Humphries, K, Sullivan, R. Wetzel, G. Taylor, B. J. Carter, and W. B. Guggino. 2003. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum. Gene Ther. 14:1079-1088.
-
(2003)
Hum. Gene Ther.
, vol.14
, pp. 1079-1088
-
-
Flotte, T.R.1
Zeitlin, P.L.2
Reynolds, T.C.3
Heald, A.E.4
Pedersen, P.5
Beck, S.6
Conrad, C.K.7
Brass-Ernst, L.8
Humphries, M.9
Sullivan, K.10
Wetzel, R.11
Taylor, G.12
Carter, B.J.13
Guggino, W.B.14
-
36
-
-
0032823285
-
The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule
-
Furchner, M., A. L. Erickson, T. Allen, D. I. Watkins, A. Sette, P. R. Johnson, and C. M. Walker. 1999. The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule. J. Virol. 73:8035-8039.
-
(1999)
J. Virol.
, vol.73
, pp. 8035-8039
-
-
Furchner, M.1
Erickson, A.L.2
Allen, T.3
Watkins, D.I.4
Sette, A.5
Johnson, P.R.6
Walker, C.M.7
-
37
-
-
1942457251
-
Erythropoietin gene therapy leads to autoimmune anemia in macaques
-
Gao, G., C. Lebherz, D. J. Weiner, R. Grant, R. Calcedo, B. McCullough, A. Bagg, Y. Zhang, and J. M. Wilson. 2004. Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 103:3300-3302.
-
(2004)
Blood
, vol.103
, pp. 3300-3302
-
-
Gao, G.1
Lebherz, C.2
Weiner, D.J.3
Grant, R.4
Calcedo, R.5
McCullough, B.6
Bagg, A.7
Zhang, Y.8
Wilson, J.M.9
-
38
-
-
0037015049
-
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
-
Gao, G. P., M. R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J. M. Wilson. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99:11854-11859.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 11854-11859
-
-
Gao, G.P.1
Alvira, M.R.2
Wang, L.3
Calcedo, R.4
Johnston, J.5
Wilson, J.M.6
-
39
-
-
0032728566
-
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
-
Glushakova, S., Y. Yi, J. C. Grivel, A. Singh, D. Schols, E. De Clercq, R. G. Collman, and L. Margolis. 1999. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J. Clin. Investig. 104:R7-R11.
-
(1999)
J. Clin. Investig.
, vol.104
-
-
Glushakova, S.1
Yi, Y.2
Grivel, J.C.3
Singh, A.4
Schols, D.5
De Clercq, E.6
Collman, R.G.7
Margolis, L.8
-
40
-
-
0036181247
-
Clinical trials of HIV vaccines
-
Graham, B. S. 2002. Clinical trials of HIV vaccines. Annu. Rev. Med. 53:207-221.
-
(2002)
Annu. Rev. Med.
, vol.53
, pp. 207-221
-
-
Graham, B.S.1
-
41
-
-
0034046182
-
DNA vaccines: Immunology, application, and optimization
-
Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18:927-974.
-
(2000)
Annu. Rev. Immunol.
, vol.18
, pp. 927-974
-
-
Gurunathan, S.1
Klinman, D.M.2
Seder, R.A.3
-
42
-
-
0033960160
-
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
-
Halbert, C. L., E. A. Rutledge, J. M. Allen, D. W. Russell, and A. D. Miller. 2000. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74:1524-1532.
-
(2000)
J. Virol.
, vol.74
, pp. 1524-1532
-
-
Halbert, C.L.1
Rutledge, E.A.2
Allen, J.M.3
Russell, D.W.4
Miller, A.D.5
-
43
-
-
0035132287
-
SF162P3
-
SF162P3. J. Virol. 75:1990-1995.
-
(2001)
J. Virol.
, vol.75
, pp. 1990-1995
-
-
Harouse, J.M.1
Gettie, A.2
Eshetu, T.3
Tan, R.C.4
Bohm, R.5
Blanchard, J.6
Baskin, G.7
Cheng-Mayer, C.8
-
44
-
-
0033617547
-
Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
-
Harouse, J. M., A. Gettie, R. C. Tan, J. Blanchard, and C. Cheng-Mayer. 1999. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284:816-819.
-
(1999)
Science
, vol.284
, pp. 816-819
-
-
Harouse, J.M.1
Gettie, A.2
Tan, R.C.3
Blanchard, J.4
Cheng-Mayer, C.5
-
45
-
-
0035393637
-
Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIV(SF33A2) map to env region
-
Harouse, J. M., A. Gettie, R. C. Tan, T. Eshetu, M. Ratterree, J. Blanchard, and C. Cheng-Mayer. 2001. Pathogenic determinants of the mucosally transmissible CXCR4-specific SHIV(SF33A2) map to env region. J. Acquir. Immune Defic. Syndr. 27:222-228.
-
(2001)
J. Acquir. Immune Defic. Syndr.
, vol.27
, pp. 222-228
-
-
Harouse, J.M.1
Gettie, A.2
Tan, R.C.3
Eshetu, T.4
Ratterree, M.5
Blanchard, J.6
Cheng-Mayer, C.7
-
46
-
-
0032036525
-
In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): Correlation to in vivo outcome
-
Harouse, J. M., R. C. Tan, A. Gettie, P. Dailey, P. A. Marx, P. A. Luciw, and C. Cheng-Mayer. 1998. In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome. J. Med. Primatol. 27:81-86.
-
(1998)
J. Med. Primatol.
, vol.27
, pp. 81-86
-
-
Harouse, J.M.1
Tan, R.C.2
Gettie, A.3
Dailey, P.4
Marx, P.A.5
Luciw, P.A.6
Cheng-Mayer, C.7
-
47
-
-
0344352497
-
Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques
-
Harouse, J. M., R. C. Tan, A. Gettie, P. Dailey, P. A. Marx, P. A. Luciw, and C. Cheng-Mayer. 1998. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques. Virology 248:95-107.
-
(1998)
Virology
, vol.248
, pp. 95-107
-
-
Harouse, J.M.1
Tan, R.C.2
Gettie, A.3
Dailey, P.4
Marx, P.A.5
Luciw, P.A.6
Cheng-Mayer, C.7
-
48
-
-
0021690155
-
Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells
-
Hermonat, P. L., and N. Muzyczka. 1984. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA 81:6466-6470.
-
(1984)
Proc. Natl. Acad. Sci. USA
, vol.81
, pp. 6466-6470
-
-
Hermonat, P.L.1
Muzyczka, N.2
-
49
-
-
1542740191
-
AAV-mediated gene transfer to skeletal muscle
-
Herzog, R. W. 2004. AAV-mediated gene transfer to skeletal muscle. Methods Mol. Biol. 246:179-194.
-
(2004)
Methods Mol. Biol.
, vol.246
, pp. 179-194
-
-
Herzog, R.W.1
-
50
-
-
0034968125
-
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer
-
Hildinger, M., A. Auricchio, G. Gao, L. Wang, N. Chirmule, and J. M. Wilson. 2001. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75:6199-6203.
-
(2001)
J. Virol.
, vol.75
, pp. 6199-6203
-
-
Hildinger, M.1
Auricchio, A.2
Gao, G.3
Wang, L.4
Chirmule, N.5
Wilson, J.M.6
-
51
-
-
0024394010
-
An African primate lentivirus (SIVsm) closely related to HIV-2
-
Hirsch, V. M., R. A. Olmsted, M. Murphey-Corb, R. H. Purcell, and P. R. Johnson. 1989. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339:389-392.
-
(1989)
Nature
, vol.339
, pp. 389-392
-
-
Hirsch, V.M.1
Olmsted, R.A.2
Murphey-Corb, M.3
Purcell, R.H.4
Johnson, P.R.5
-
52
-
-
0025874640
-
Simian immunodeficiency virus infection of macaques: End-stage disease is characterized by widespread distribution of proviral DNA in tissues
-
Hirsch, V. M., P. M. Zack, A. P. Vogel, and P. R. Johnson. 1991. Simian immunodeficiency virus infection of macaques: end-stage disease is characterized by widespread distribution of proviral DNA in tissues. J. Infect. Dis. 163:976-988.
-
(1991)
J. Infect. Dis.
, vol.163
, pp. 976-988
-
-
Hirsch, V.M.1
Zack, P.M.2
Vogel, A.P.3
Johnson, P.R.4
-
53
-
-
0034772681
-
Technology evaluation: Anticancer gene therapy, MediGene
-
Hunt, S. 2001. Technology evaluation: anticancer gene therapy, MediGene. Curr. Opin. Mol. Ther. 3:509-514.
-
(2001)
Curr. Opin. Mol. Ther.
, vol.3
, pp. 509-514
-
-
Hunt, S.1
-
54
-
-
0035895214
-
+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
-
+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. USA 98:658-663.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 658-663
-
-
Igarashi, T.1
Brown, C.R.2
Endo, Y.3
Buckler-White, A.4
Plishka, R.5
Bischofberger, N.6
Hirsch, V.7
Martin, M.A.8
-
55
-
-
0026549513
-
Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge
-
Johnson, P. R., D. C. Montefiori, S. Goldstein, T. E. Hamm, J. Zhou, S. Kitov, N. L. Haigwood, L. Misher, W. T. London, J. L. Gerin, A. Allison, R. H. Purcell, R. M. Chanock, and V. M. Hirsch. 1992. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc. Natl. Acad. Sci. USA 89: 2175-2179.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 2175-2179
-
-
Johnson, P.R.1
Montefiori, D.C.2
Goldstein, S.3
Hamm, T.E.4
Zhou, J.5
Kitov, S.6
Haigwood, N.L.7
Misher, L.8
London, W.T.9
Gerin, J.L.10
Allison, A.11
Purcell, R.H.12
Chanock, R.M.13
Hirsch, V.M.14
-
56
-
-
0030451214
-
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
-
Kessler, P. D., G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 14082-14087
-
-
Kessler, P.D.1
Podsakoff, G.M.2
Chen, X.3
McQuiston, S.A.4
Colosi, P.C.5
Matelis, L.A.6
Kurtzman, G.J.7
Byrne, B.J.8
-
57
-
-
0035811833
-
Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization
-
Kim, J. J., J. S. Yang, L. K. Nottingham, D. J. Lee, M. Lee, K. H. Manson, M. S. Wyand, J. D. Boyer, K. E. Ugen, and D. B. Weiner. 2001. Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization. Virology 285:204-217.
-
(2001)
Virology
, vol.285
, pp. 204-217
-
-
Kim, J.J.1
Yang, J.S.2
Nottingham, L.K.3
Lee, D.J.4
Lee, M.5
Manson, K.H.6
Wyand, M.S.7
Boyer, J.D.8
Ugen, K.E.9
Weiner, D.B.10
-
58
-
-
0024322243
-
Organization of adeno-associated virus DNA in latently infected Detroit 6 cells
-
Kotin, R. M., and K. I. Berns. 1989. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170:460-467.
-
(1989)
Virology
, vol.170
, pp. 460-467
-
-
Kotin, R.M.1
Berns, K.I.2
-
59
-
-
0027092001
-
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination
-
Kotin, R. M., R. M. Linden, and K. I. Berns. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:5071-5078.
-
(1992)
EMBO J.
, vol.11
, pp. 5071-5078
-
-
Kotin, R.M.1
Linden, R.M.2
Berns, K.I.3
-
60
-
-
0025721086
-
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
-
Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831-834.
-
(1991)
Genomics
, vol.10
, pp. 831-834
-
-
Kotin, R.M.1
Menninger, J.C.2
Ward, D.C.3
Berns, K.I.4
-
61
-
-
0025214094
-
Site-specific integration by adeno-associated virus
-
Kotin, R. M., M. Siniscalco, R. J. Samulski, X. D. Zhu, L. Hunter, C. A. Laughlln, S. McLaughlin, N. Muzyczka, M. Rocchi, and K. I. Berns. 1990. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87:2211-2215.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 2211-2215
-
-
Kotin, R.M.1
Siniscalco, M.2
Samulski, R.J.3
Zhu, X.D.4
Hunter, L.5
Laughlln, C.A.6
McLaughlin, S.7
Muzyczka, N.8
Rocchi, M.9
Berns, K.I.10
-
62
-
-
0023731951
-
Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cell types
-
Lebkowski, J. S., M. M. McNally, T. B. Okarma, and L. B. Lerch. 1988. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8:3988-3996.
-
(1988)
Mol. Cell. Biol.
, vol.8
, pp. 3988-3996
-
-
Lebkowski, J.S.1
McNally, M.M.2
Okarma, T.B.3
Lerch, L.B.4
-
63
-
-
0034467028
-
Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice
-
Ledwith, B. J., S. Manam, P. J. Troilo, A. B. Barnum, C. J. Pauley, T. G. Griffiths II, L. B. Harper, C. M. Beare, W. J. Bagdon, and W. W. Nichols. 2000. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 43:258-272.
-
(2000)
Intervirology
, vol.43
, pp. 258-272
-
-
Ledwith, B.J.1
Manam, S.2
Troilo, P.J.3
Barnum, A.B.4
Pauley, C.J.5
Griffiths II, T.G.6
Harper, L.B.7
Beare, C.M.8
Bagdon, W.J.9
Nichols, W.W.10
-
64
-
-
0035043246
-
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope
-
Lervin, N. L., S. Robinson, D. Rohne, M. K. Axthelm, J. W. Fanton, M. Bilska, T. J. Palker, H. X. Liao, B. F. Haynes, and D. C. Montefiori. 2001. Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope. J. Virol. 75:4165-4175.
-
(2001)
J. Virol.
, vol.75
, pp. 4165-4175
-
-
Lervin, N.L.1
Robinson, S.2
Rohne, D.3
Axthelm, M.K.4
Fanton, J.W.5
Bilska, M.6
Palker, T.J.7
Liao, H.X.8
Haynes, B.F.9
Montefiori, D.C.10
-
65
-
-
0032860663
-
Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
-
Letvin, N. L., J. E. Schmitz, H. L. Jordan, A. Seth, V. M. Hirsch, K. A. Reimann, and M. J. Kuroda. 1999. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus. Immunol. Rev. 170:127-134.
-
(1999)
Immunol. Rev.
, vol.170
, pp. 127-134
-
-
Letvin, N.L.1
Schmitz, J.E.2
Jordan, H.L.3
Seth, A.4
Hirsch, V.M.5
Reimann, K.A.6
Kuroda, M.J.7
-
66
-
-
0036340378
-
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer
-
Lewis, A. D., R. Chen, D. C. Montefiori, P. R. Johnson, and K. R. Clark. 2002. Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer. J. Virol. 76:8769-8775.
-
(2002)
J. Virol.
, vol.76
, pp. 8769-8775
-
-
Lewis, A.D.1
Chen, R.2
Montefiori, D.C.3
Johnson, P.R.4
Clark, K.R.5
-
67
-
-
0037122772
-
One step forwards, one step back
-
Lifson, J. D., and M. A. Martin. 2002. One step forwards, one step back. Nature 415:272-273.
-
(2002)
Nature
, vol.415
, pp. 272-273
-
-
Lifson, J.D.1
Martin, M.A.2
-
68
-
-
0033994625
-
Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
-
Liu, D. W., Y. P. Tsao, J. T. Kung, Y. A. Ding, H. K. Sytwu, X. Xiao, and S. L. Chen. 2000. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J. Virol. 74:2888-2894.
-
(2000)
J. Virol.
, vol.74
, pp. 2888-2894
-
-
Liu, D.W.1
Tsao, Y.P.2
Kung, J.T.3
Ding, Y.A.4
Sytwu, H.K.5
Xiao, X.6
Chen, S.L.7
-
69
-
-
0031058475
-
Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line
-
Malik, P., S. A. McQuiston, X. J. Yu, K. A. Pepper, W. J. Krall, G. M. Podsakoff, G. J. Kurtzman, and D. B. Kohn. 1997. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71:1776-1783.
-
(1997)
J. Virol.
, vol.71
, pp. 1776-1783
-
-
Malik, P.1
McQuiston, S.A.2
Yu, X.J.3
Pepper, K.A.4
Krall, W.J.5
Podsakoff, G.M.6
Kurtzman, G.J.7
Kohn, D.B.8
-
70
-
-
0034469447
-
Plasmid DNA vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA
-
Manam, S., B. J. Ledwith, A. B. Barnum, P. J. Troilo, C. J. Pauley, L. B. Harper, T. G. Griffiths II, Z. Niu, L. Denisova, T. T. Follmer, S. J. Pacchione, Z. Wang, C. M. Beare, W. J. Bagdon, and W. W. Nichols. 2000. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43:273-281.
-
(2000)
Intervirology
, vol.43
, pp. 273-281
-
-
Manam, S.1
Ledwith, B.J.2
Barnum, A.B.3
Troilo, P.J.4
Pauley, C.J.5
Harper, L.B.6
Griffiths II, T.G.7
Niu, Z.8
Denisova, L.9
Follmer, T.T.10
Pacchione, S.J.11
Wang, Z.12
Beare, C.M.13
Bagdon, W.J.14
Nichols, W.W.15
-
71
-
-
0030819372
-
Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D
-
Manning, W. C., X. Paliard, S. Zhou, M. P. Bland, A. Y. Lee, K. Hong, C. M. Walker, J. A. Escobedo, and V. Dwarki. 1997. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J. Virol. 71:7960-7962.
-
(1997)
J. Virol.
, vol.71
, pp. 7960-7962
-
-
Manning, W.C.1
Paliard, X.2
Zhou, S.3
Bland, M.P.4
Lee, A.Y.5
Hong, K.6
Walker, C.M.7
Escobedo, J.A.8
Dwarki, V.9
-
72
-
-
0013442744
-
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
-
Manno, C. S., A. J. Chew, S. Hutchison, P. J. Larson, R. W. Herzog, V. R. Arruda, S. J. Tai, M. V. Ragni, A. Thompson, M. Ozelo, L. B. Couto, D. G. Leonard, F. A. Johnson, A. McClelland, C. Scallan, E. Skarsgard, A. W. Flake, M. A. Kay, K. A. High, and B. Glader. 2003. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101:2963-2972.
-
(2003)
Blood
, vol.101
, pp. 2963-2972
-
-
Manno, C.S.1
Chew, A.J.2
Hutchison, S.3
Larson, P.J.4
Herzog, R.W.5
Arruda, V.R.6
Tai, S.J.7
Ragni, M.V.8
Thompson, A.9
Ozelo, M.10
Couto, L.B.11
Leonard, D.G.12
Johnson, F.A.13
McClelland, A.14
Scallan, C.15
Skarsgard, E.16
Flake, A.W.17
Kay, M.A.18
High, K.A.19
Glader, B.20
more..
-
73
-
-
0036134852
-
Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys
-
McKay, P. F., J. E. Schmitz, D. H. Barouch, M. J. Kuroda, M. A. Lifton, C. E. Nickerson, D. A. Gorgone, and N. L. Letvin. 2002. Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys. J. Immunol. 168:332-337.
-
(2002)
J. Immunol.
, vol.168
, pp. 332-337
-
-
McKay, P.F.1
Schmitz, J.E.2
Barouch, D.H.3
Kuroda, M.J.4
Lifton, M.A.5
Nickerson, C.E.6
Gorgone, D.A.7
Letvin, N.L.8
-
74
-
-
0023889191
-
Adeno-associated virus general transduction vectors: Analysis of proviral structures
-
McLaughlin, S. K., P. Collis, P. L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
-
(1988)
J. Virol.
, vol.62
, pp. 1963-1973
-
-
McLaughlin, S.K.1
Collis, P.2
Hermonat, P.L.3
Muzyczka, N.4
-
75
-
-
0036478954
-
Chromosomal effects of adeno-associated virus vector integration
-
Miller, D. G., E. A. Rutledge, and D. W. Russell. 2002. Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30:147-148.
-
(2002)
Nat. Genet.
, vol.30
, pp. 147-148
-
-
Miller, D.G.1
Rutledge, E.A.2
Russell, D.W.3
-
76
-
-
2542505511
-
Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques
-
Miyake, A., T. Akagi, Y. Enose, M. Ueno, M. Kawamura, R. Horiuchi, K. Hiraishi, M. Adachi, T. Serizawa, O. Narayan, M. Akashi, M. Baba, and M. Hayami. 2004. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. J. Med. Virol. 73:368-377.
-
(2004)
J. Med. Virol.
, vol.73
, pp. 368-377
-
-
Miyake, A.1
Akagi, T.2
Enose, Y.3
Ueno, M.4
Kawamura, M.5
Horiuchi, R.6
Hiraishi, K.7
Adachi, M.8
Serizawa, T.9
Narayan, O.10
Akashi, M.11
Baba, M.12
Hayami, M.13
-
77
-
-
0009963512
-
Safety of adeno-associated virus gene therapy vectors: A current evaluation
-
Monahan, P. E., K. Jooss, and M. S. Sands. 2002. Safety of adeno-associated virus gene therapy vectors: a current evaluation. Expert Opin. Drug Safety 1:79-91.
-
(2002)
Expert Opin. Drug Safety
, vol.1
, pp. 79-91
-
-
Monahan, P.E.1
Jooss, K.2
Sands, M.S.3
-
78
-
-
10744227749
-
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial
-
Moss, R. B., D. Rodman, L. T. Spencer, M. L. Aitken, P. L. Zeitlin, D. Waltz, C. Milla, A. S. Brody, J. P. Clancy, B. Ramsey, N. Hamblett, and A. E. Heald. 2004. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125:509-521.
-
(2004)
Chest
, vol.125
, pp. 509-521
-
-
Moss, R.B.1
Rodman, D.2
Spencer, L.T.3
Aitken, M.L.4
Zeitlin, P.L.5
Waltz, D.6
Milla, C.7
Brody, A.S.8
Clancy, J.P.9
Ramsey, B.10
Hamblett, N.11
Heald, A.E.12
-
79
-
-
0041707676
-
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses
-
O'Connor, D. H., B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A. B. McDermott, T. M. Allen, C. Wang, G. G. Doxiadis, D. C. Montefiori, A. Hughes, D. R. Burton, D. B. Allison, S. M. Wolinsky, R. Bontrop, L. J. Picker, and D. I. Watkins. 2003. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77:9029-9040.
-
(2003)
J. Virol.
, vol.77
, pp. 9029-9040
-
-
O'Connor, D.H.1
Mothe, B.R.2
Weinfurter, J.T.3
Fuenger, S.4
Rehrauer, W.M.5
Jing, P.6
Rudersdorf, R.R.7
Liebl, M.E.8
Krebs, K.9
Vasquez, J.10
Dodds, E.11
Loffredo, J.12
Martin, S.13
McDermott, A.B.14
Allen, T.M.15
Wang, C.16
Doxiadis, G.G.17
Montefiori, D.C.18
Hughes, A.19
Burton, D.R.20
Allison, D.B.21
Wolinsky, S.M.22
Bontrop, R.23
Picker, L.J.24
Watkins, D.I.25
more..
-
80
-
-
0033995525
-
Recombinant modified vaccinia virus Ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques
-
Ourmanov, I., M. Bilska, V. M. Hirsch, and D. C. Montefiori. 2000. Recombinant modified vaccinia virus Ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques. J. Virol. 74:2960-2965.
-
(2000)
J. Virol.
, vol.74
, pp. 2960-2965
-
-
Ourmanov, I.1
Bilska, M.2
Hirsch, V.M.3
Montefiori, D.C.4
-
81
-
-
0034864776
-
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
-
Parren, P. W., P. A. Marx, A. J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J. P. Moore, and D. R. Burton. 2001. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
-
(2001)
J. Virol.
, vol.75
, pp. 8340-8347
-
-
Parren, P.W.1
Marx, P.A.2
Hessell, A.J.3
Luckay, A.4
Harouse, J.5
Cheng-Mayer, C.6
Moore, J.P.7
Burton, D.R.8
-
82
-
-
2642537522
-
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
-
Peden, C. S., C. Burger, N. Muzyczka, and R. J. Mandel. 2004. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J. Virol. 78:6344-6359.
-
(2004)
J. Virol.
, vol.78
, pp. 6344-6359
-
-
Peden, C.S.1
Burger, C.2
Muzyczka, N.3
Mandel, R.J.4
-
83
-
-
0036140216
-
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
-
Rabinowitz, J. E., F. Rolling, C. Li, H. Conrath, W. Xiao, X. Xiao, and R. J. Samulski. 2002. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76:791-801.
-
(2002)
J. Virol.
, vol.76
, pp. 791-801
-
-
Rabinowitz, J.E.1
Rolling, F.2
Li, C.3
Conrath, H.4
Xiao, W.5
Xiao, X.6
Samulski, R.J.7
-
84
-
-
1842432465
-
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol
-
Ramsburg, E., N. F. Rose, P. A. Marx, M. Mefford, D. F. Nixon, W. J. Moretto, D. Montefiori, P. Earl, B. Moss, and J. K. Rose. 2004. Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol. J. Virol. 78:3930-3940.
-
(2004)
J. Virol.
, vol.78
, pp. 3930-3940
-
-
Ramsburg, E.1
Rose, N.F.2
Marx, P.A.3
Mefford, M.4
Nixon, D.F.5
Moretto, W.J.6
Montefiori, D.7
Earl, P.8
Moss, B.9
Rose, J.K.10
-
85
-
-
17944369239
-
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
-
Rose, N. F., P. A. Marx, A. Luckay, D. F. Nixon, W. J. Moretto, S. M. Donahoe, D. Montefiori, A. Roberts, L. Buonocore, and J. K. Rose. 2001. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106:539-549.
-
(2001)
Cell
, vol.106
, pp. 539-549
-
-
Rose, N.F.1
Marx, P.A.2
Luckay, A.3
Nixon, D.F.4
Moretto, W.J.5
Donahoe, S.M.6
Montefiori, D.7
Roberts, A.8
Buonocore, L.9
Rose, J.K.10
-
86
-
-
0031984786
-
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
-
Rutledge, E. A., C. L. Halhert, and D. W. Russell. 1998. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72:309-319.
-
(1998)
J. Virol.
, vol.72
, pp. 309-319
-
-
Rutledge, E.A.1
Halhert, C.L.2
Russell, D.W.3
-
87
-
-
0030773872
-
Adeno-associated virus vector integration junctions
-
Rutledge, E. A., and D. W. Russell. 1997. Adeno-associated virus vector integration junctions. J. Virol. 71:8429-8436.
-
(1997)
J. Virol.
, vol.71
, pp. 8429-8436
-
-
Rutledge, E.A.1
Russell, D.W.2
-
88
-
-
0026070440
-
Targeted integration of adeno-associated virus (AAV) into human chromosome 19
-
Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950.
-
(1991)
EMBO J.
, vol.10
, pp. 3941-3950
-
-
Samulski, R.J.1
Zhu, X.2
Xiao, X.3
Brook, J.D.4
Housman, D.E.5
Epstein, N.6
Hunter, L.A.7
-
89
-
-
0035006080
-
Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases
-
Sasaki, S., R. R. Amara, A. E. Oran, J. M. Smith, and H. L. Robinson. 2001. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat. Biotechnol. 19:543-547.
-
(2001)
Nat. Biotechnol.
, vol.19
, pp. 543-547
-
-
Sasaki, S.1
Amara, R.R.2
Oran, A.E.3
Smith, J.M.4
Robinson, H.L.5
-
90
-
-
0037333815
-
Genetic fate of recombinant adeno-associated virus vector genomes in muscle
-
Schnepp, B. C., K. R. Clark, D. L. Klemanski, C. A. Pacak, and P. R. Johnson. 2003. Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J. Virol. 77:3495-3504.
-
(2003)
J. Virol.
, vol.77
, pp. 3495-3504
-
-
Schnepp, B.C.1
Clark, K.R.2
Klemanski, D.L.3
Pacak, C.A.4
Johnson, P.R.5
-
91
-
-
0034088113
-
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
-
Seth, A., I. Ourmanov, J. E. Schmitz, M. J. Kuroda, M. A. Lifton, C. E. Nickerson, L. Wyatt, M. Carroll, B. Moss, D. Venzon, N. L. Letvin, and V. M. Hirsch. 2000. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J. Virol. 74:2502-2509.
-
(2000)
J. Virol.
, vol.74
, pp. 2502-2509
-
-
Seth, A.1
Ourmanov, I.2
Schmitz, J.E.3
Kuroda, M.J.4
Lifton, M.A.5
Nickerson, C.E.6
Wyatt, L.7
Carroll, M.8
Moss, B.9
Venzon, D.10
Letvin, N.L.11
Hirsch, V.M.12
-
92
-
-
0034088881
-
Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse
-
Sferra, T. J., G. Qu, D. McNeely, R. Rennard, K. R. Clark, W. D. Lo, and P. R. Johnson. 2000. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum. Gene Ther. 11:507-519.
-
(2000)
Hum. Gene Ther.
, vol.11
, pp. 507-519
-
-
Sferra, T.J.1
Qu, G.2
McNeely, D.3
Rennard, R.4
Clark, K.R.5
Lo, W.D.6
Johnson, P.R.7
-
93
-
-
0030855058
-
Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing
-
Shibata, R., F. Maldarelli, C. Siemon, T. Matano, M. Parla, G. Miller, T. Fredrickson, and M. A. Martin. 1997. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176:362-373.
-
(1997)
J. Infect. Dis.
, vol.176
, pp. 362-373
-
-
Shibata, R.1
Maldarelli, F.2
Siemon, C.3
Matano, T.4
Parla, M.5
Miller, G.6
Fredrickson, T.7
Martin, M.A.8
-
94
-
-
1542299092
-
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
-
Shiver, J. W., and E. A. Emini. 2004. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55:355-372.
-
(2004)
Annu. Rev. Med.
, vol.55
, pp. 355-372
-
-
Shiver, J.W.1
Emini, E.A.2
-
95
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
Shiver, J. W., T. M. Fu, L. Chen, D. R. Casimiro, M. E. Davies, R. K. Evans, Z. Q. Zhang, A. J. Simon, W. L. Trigona, S. A. Dubey, L. Huang, V. A. Harris, R. S. Long, X. Liang, L. Handt, W. A. Schleif, L. Zhu, D. C. Freed, N. V. Persaud, L. Guan, K. S. Punt, A. Tang, M. Chen, K. A. Wilson, K. B. Collins, G. J. Heidecker, V. R. Fernandez, H. C. Perry, J. G. Joyce, K. M. Grimm, J. C. Cook, P. M. Keller, D. S. Kresock, H. Mach, R. D. Troutman, L. A. Isopi, D. M. Williams, Z. Xu, K. E. Bohannon, D. B. Volkin, D. C. Montefiori, A. Miura, G. R. Krivulka, M. A. Lifton, M. J. Kuroda, J. E. Schmitz, N. L. Letvin, M. J. Caulfield, A. J. Bett, R. Youil, D. C. Kaslow, and E. A. Emini. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335.
-
(2002)
Nature
, vol.415
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.M.2
Chen, L.3
Casimiro, D.R.4
Davies, M.E.5
Evans, R.K.6
Zhang, Z.Q.7
Simon, A.J.8
Trigona, W.L.9
Dubey, S.A.10
Huang, L.11
Harris, V.A.12
Long, R.S.13
Liang, X.14
Handt, L.15
Schleif, W.A.16
Zhu, L.17
Freed, D.C.18
Persaud, N.V.19
Guan, L.20
Punt, K.S.21
Tang, A.22
Chen, M.23
Wilson, K.A.24
Collins, K.B.25
Heidecker, G.J.26
Fernandez, V.R.27
Perry, H.C.28
Joyce, J.G.29
Grimm, K.M.30
Cook, J.C.31
Keller, P.M.32
Kresock, D.S.33
Mach, H.34
Troutman, R.D.35
Isopi, L.A.36
Williams, D.M.37
Xu, Z.38
Bohannon, K.E.39
Volkin, D.B.40
Montefiori, D.C.41
Miura, A.42
Krivulka, G.R.43
Lifton, M.A.44
Kuroda, M.J.45
Schmitz, J.E.46
Letvin, N.L.47
Caulfield, M.J.48
Bett, A.J.49
Youil, R.50
Kaslow, D.C.51
Emini, E.A.52
more..
-
96
-
-
0030671462
-
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice
-
Snyder, R. O., S. K. Spratt, C. Lagarde, D. Bohl, B. Kaspar, B. Sloan, L. K. Cohen, and O. Danos. 1997. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8:1891-1900.
-
(1997)
Hum. Gene Ther.
, vol.8
, pp. 1891-1900
-
-
Snyder, R.O.1
Spratt, S.K.2
Lagarde, C.3
Bohl, D.4
Kaspar, B.5
Sloan, B.6
Cohen, L.K.7
Danos, O.8
-
97
-
-
0031594394
-
A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route
-
Sodora, D. L., F. Lee, P. J. Dailey, and P. A. Marx. 1998. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res. Hum. Retrovir. 14:171-181.
-
(1998)
AIDS Res. Hum. Retrovir.
, vol.14
, pp. 171-181
-
-
Sodora, D.L.1
Lee, F.2
Dailey, P.J.3
Marx, P.A.4
-
98
-
-
13144305062
-
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
-
Song, S., M. Morgan, T. Ellis, A. Poirier, K. Chesnut, J. Wang, M. Brantly, N. Muzyczka, B. J. Byrne, M. Atkinson, and T. R. Flotte. 1998. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95:14384-14388.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 14384-14388
-
-
Song, S.1
Morgan, M.2
Ellis, T.3
Poirier, A.4
Chesnut, K.5
Wang, J.6
Brantly, M.7
Muzyczka, N.8
Byrne, B.J.9
Atkinson, M.10
Flotte, T.R.11
-
99
-
-
0036764793
-
Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: Safety and immunologic aspects
-
Song, S., M. Scott-Jorgensen, J. Wang, A. Poirier, J. Crawford, M. Campbell-Thompson, and T. R. Flotte. 2002. Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects. Mol. Ther. 6:329-335.
-
(2002)
Mol. Ther.
, vol.6
, pp. 329-335
-
-
Song, S.1
Scott-Jorgensen, M.2
Wang, J.3
Poirier, A.4
Crawford, J.5
Campbell-Thompson, M.6
Flotte, T.R.7
-
100
-
-
0038103349
-
Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy
-
Sun, J. Y., S. Chatterjee, and K. K. Wong, Jr. 2002. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy. Curr. Gene Ther. 2:485-500.
-
(2002)
Curr. Gene Ther.
, vol.2
, pp. 485-500
-
-
Sun, J.Y.1
Chatterjee, S.2
Wong Jr., K.K.3
-
101
-
-
0022226995
-
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells
-
Tratschin, J. D., I. L. Miller, M. G. Smith, and B. J. Carter. 1985. Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol. Cell. Biol. 5:3251-3260.
-
(1985)
Mol. Cell. Biol.
, vol.5
, pp. 3251-3260
-
-
Tratschin, J.D.1
Miller, I.L.2
Smith, M.G.3
Carter, B.J.4
-
102
-
-
0033022349
-
Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus
-
Wagner, J. A., A. H. Messner, M. L. Moran, R. Daifuku, K. Kouyama, J. K. Desch, S. Manley, A. M. Norbash, C. K. Conrad, S. Friborg, T. Reynolds, W. B. Guggino, R. B. Moss, B. J. Carter, J. J. Wine, T. R. Flotte, and P. Gardner. 1999. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109:266-274.
-
(1999)
Laryngoscope
, vol.109
, pp. 266-274
-
-
Wagner, J.A.1
Messner, A.H.2
Moran, M.L.3
Daifuku, R.4
Kouyama, K.5
Desch, J.K.6
Manley, S.7
Norbash, A.M.8
Conrad, C.K.9
Friborg, S.10
Reynolds, T.11
Guggino, W.B.12
Moss, R.B.13
Carter, B.J.14
Wine, J.J.15
Flotte, T.R.16
Gardner, P.17
-
103
-
-
0026660060
-
Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector
-
Walsh, C. E., J. M. Liu, X. Xiao, N. S. Young, A. W. Nienhuis, and R. J. Samulski. 1992. Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89:7257-7261.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 7257-7261
-
-
Walsh, C.E.1
Liu, J.M.2
Xiao, X.3
Young, N.S.4
Nienhuis, A.W.5
Samulski, R.J.6
-
104
-
-
11144356610
-
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
-
Wang, Z., P. J. Troilo, X. Wang, T. G. Griffiths, S. J. Pacchione, A. B. Barnum, L. B. Harper, C. J. Pauley, Z. Niu, L. Denisova, T. T. Follmer, G. Rizzuto, G. Ciliberto, E. Fattori, N. L. Monica, S. Manam, and B. J. Ledwith. 2004. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther. 11:711-721.
-
(2004)
Gene Ther.
, vol.11
, pp. 711-721
-
-
Wang, Z.1
Troilo, P.J.2
Wang, X.3
Griffiths, T.G.4
Pacchione, S.J.5
Barnum, A.B.6
Harper, L.B.7
Pauley, C.J.8
Niu, Z.9
Denisova, L.10
Follmer, T.T.11
Rizzuto, G.12
Ciliberto, G.13
Fattori, E.14
Monica, N.L.15
Manam, S.16
Ledwith, B.J.17
-
105
-
-
0036385643
-
Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice
-
Watchko, J., T. O'Day, B. Wang, L. Zhou, Y. Tang, J. Li, and X. Xiao. 2002. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 13:1451-1460.
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 1451-1460
-
-
Watchko, J.1
O'Day, T.2
Wang, B.3
Zhou, L.4
Tang, Y.5
Li, J.6
Xiao, X.7
-
106
-
-
0037228024
-
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
-
Willey, R. L., R. Byrum, M. Piatak, Y. B. Kim, M. W. Cho, J. L. Rossio, Jr., J. Bess, Jr., T. Igarashi, Y. Endo, L. O. Arthur, J. D. Lifson, and M. A. Martin. 2003. Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles. J. Virol. 77:1163-1174.
-
(2003)
J. Virol.
, vol.77
, pp. 1163-1174
-
-
Willey, R.L.1
Byrum, R.2
Piatak, M.3
Kim, Y.B.4
Cho, M.W.5
Rossio Jr., J.L.6
Bess Jr., J.7
Igarashi, T.8
Endo, Y.9
Arthur, L.O.10
Lifson, J.D.11
Martin, M.A.12
-
107
-
-
0028356571
-
Plasmid integration, amplification and cytogenetics in CHO cells: Questions and comments
-
Wurm, F. M., and C. J. Petropoulos. 1994. Plasmid integration, amplification and cytogenetics in CHO cells: questions and comments. Biologicals 22:95-102.
-
(1994)
Biologicals
, vol.22
, pp. 95-102
-
-
Wurm, F.M.1
Petropoulos, C.J.2
-
108
-
-
0032849066
-
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge
-
Wyand, M. S., K. Manson, D. C. Montefiori, J. D. Lifson, R. P. Johnson, and R. C. Desrosiers. 1999. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73:8356-8363.
-
(1999)
J. Virol.
, vol.73
, pp. 8356-8363
-
-
Wyand, M.S.1
Manson, K.2
Montefiori, D.C.3
Lifson, J.D.4
Johnson, R.P.5
Desrosiers, R.C.6
-
109
-
-
0032924185
-
Gene therapy vectors based on adeno-associated virus type 1
-
Xiao, W., N. Chirmule, S. C. Berta, B. McCullough, G. Gao, and J. M. Wilson. 1999. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73:3994-4003.
-
(1999)
J. Virol.
, vol.73
, pp. 3994-4003
-
-
Xiao, W.1
Chirmule, N.2
Berta, S.C.3
McCullough, B.4
Gao, G.5
Wilson, J.M.6
-
110
-
-
0029843596
-
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
-
Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
-
(1996)
J. Virol.
, vol.70
, pp. 8098-8108
-
-
Xiao, X.1
Li, J.2
Samulski, R.J.3
-
111
-
-
0036375003
-
Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses
-
Xin, K. Q., T. Ooki, H. Mizukami, K. Hamajima, K. Okudela, K. Hashimoto, Y. Kojima, N. Jounai, Y. Kumamoto, S. Sasaki, D. Klinman, K. Ozawa, and K. Okuda. 2002. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses. Hum. Gene Ther. 13:1571-1581.
-
(2002)
Hum. Gene Ther.
, vol.13
, pp. 1571-1581
-
-
Xin, K.Q.1
Ooki, T.2
Mizukami, H.3
Hamajima, K.4
Okudela, K.5
Hashimoto, K.6
Kojima, Y.7
Jounai, N.8
Kumamoto, Y.9
Sasaki, S.10
Klinman, D.11
Ozawa, K.12
Okuda, K.13
-
112
-
-
0034921072
-
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
-
Xin, K. Q., M. Urabe, J. Yang, K. Nomiyama, H. Mizukami, K. Hamajima, H. Nomiyama, T. Saito, M. Imai, J. Monahan, K. Okuda, and K. Ozawa. 2001. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12:1047-1061.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 1047-1061
-
-
Xin, K.Q.1
Urabe, M.2
Yang, J.3
Nomiyama, K.4
Mizukami, H.5
Hamajima, K.6
Nomiyama, H.7
Saito, T.8
Imai, M.9
Monahan, J.10
Okuda, K.11
Ozawa, K.12
-
113
-
-
0036892308
-
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product
-
Yuasa, K., M. Sakamoto, Y. Miyagoe-Suzuki, A. Tanouchi, H. Yamamoto, J. Li, J. S. Chamberlain, X. Xiao, and S. Takeda. 2002. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther. 9:1576-1588.
-
(2002)
Gene Ther.
, vol.9
, pp. 1576-1588
-
-
Yuasa, K.1
Sakamoto, M.2
Miyagoe-Suzuki, Y.3
Tanouchi, A.4
Yamamoto, H.5
Li, J.6
Chamberlain, J.S.7
Xiao, X.8
Takeda, S.9
-
114
-
-
0036227449
-
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
-
Zaiss, A. K., Q. Liu, G. P. Bowen, N. C. Wong, J. S. Bartlett, and D. A. Muruve. 2002. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J. Virol. 76:4580-4590.
-
(2002)
J. Virol.
, vol.76
, pp. 4580-4590
-
-
Zaiss, A.K.1
Liu, Q.2
Bowen, G.P.3
Wong, N.C.4
Bartlett, J.S.5
Muruve, D.A.6
-
115
-
-
0036882075
-
Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection
-
Zhang, Z. Q., T. M. Fu, D. R. Casimiro, M. E. Davies, X. Liang, W. A. Schleif, L. Handt, L. Tussey, M. Chen, A. Tang, K. A. Wilson, W. L. Trigona, D. C. Freed, C. Y. Tan, M. Horton, E. A. Emini, and J. W. Shiver. 2002. Mamu-A*01 allele-mediated attenuation of disease progression in simian-human immunodeficiency virus infection. J. Virol. 76:12845-12854.
-
(2002)
J. Virol.
, vol.76
, pp. 12845-12854
-
-
Zhang, Z.Q.1
Fu, T.M.2
Casimiro, D.R.3
Davies, M.E.4
Liang, X.5
Schleif, W.A.6
Handt, L.7
Tussey, L.8
Chen, M.9
Tang, A.10
Wilson, K.A.11
Trigona, W.L.12
Freed, D.C.13
Tan, C.Y.14
Horton, M.15
Emini, E.A.16
Shiver, J.W.17
|